Related Experiment Video

Updated: Sep 23, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells

Yi Huang1, Erin R Hager, Dawn L Phillips

  • 1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|July 12, 2003
PubMed

Insights

The novel polyamine analog SL11144 effectively combats human breast cancer by reducing cell proliferation and inducing apoptosis. This compound shows promise in both in vitro and in vivo models, offering a new avenue for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Polyamine analogs show promise against solid tumors, including breast cancer.
  • The exact mechanisms behind their antitumor effects require further elucidation.
  • Understanding these mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To assess the cytotoxicity of a new polyamine analog, SL11144, against human breast cancer.
  • To investigate the molecular mechanisms underlying SL11144's antitumor activity.
  • To evaluate the in vivo efficacy and safety of SL11144.

Main Methods:

  • Assessed cytotoxicity in human breast cancer cell lines (in vitro).
  • Evaluated tumor growth inhibition in MDA-MB-231 xenografts (in vivo).
  • Analyzed apoptotic markers (cytochrome c, caspase-3, PARP cleavage, Bcl-2/Bax ratio) and transcription factor activity (c-Jun).
  • Measured ornithine decarboxylase activity and polyamine pools.

Main Results:

  • SL11144 reduced breast cancer cell proliferation and induced apoptosis dose- and time-dependently.
  • SL11144 inhibited tumor growth in vivo without significant toxicity.
  • Apoptotic pathways involving cytochrome c release, caspase-3 activation, and altered Bcl-2/Bax ratios were observed.
  • SL11144 modulated c-Jun expression and inhibited ornithine decarboxylase, decreasing polyamine pools.

Conclusions:

  • The novel polyamine analog SL11144 exhibits potent antineoplastic effects against human breast cancer cells.
  • SL11144's cytotoxicity is mediated by multiple apoptotic mechanisms.
  • SL11144 demonstrates potential as a therapeutic agent for breast cancer treatment.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...